IMMUNOPATHOLOGIC MECHANISMS OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


IMMUNOPATHOLOGIC MECHANISMS OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION

The Human Retroviruses. Gallo RC and Jay G, eds. San Diego, Academic Press, p. 141-61, 1991.. Unique Identifier : AIDSLINE ICDB/92678725
Rosenberg ZF; Fauci AS; Natl. Inst. of Allergy and Infectious Diseases, NIH, Bethesda, MD; 20892


Abstract: The most striking feature of infection with HIV in vivo is a dramatic reduction in the number of T4 cells, a specific subset of helper/inducer T lymphocytes that expresses the CD4 antigen. The ultimate destruction of the T4 cell population results in a critical immune deficiency that permits the development of a wide range of opportunistic infections and tumors. Immunopathology of HIV infection is reviewed, including mechanisms of T4 cell depletion (CD4 receptor in HIV infection, direct virus-induced T4 cell cytopathicity, indirect methods of T4 cell cytopathicity); impairment of immune system function (functional abnormalities of T4 cells, effects of HIV on other immune cells, and HIV infection of other cell types); role of the monocyte/macrophage in HIV infection; mechanisms of HIV-induced neurological disease; activation of latent HIV infection; and subversion of the immune system by HIV. It is becoming increasingly clear that initial infection with HIV and activation of HIV from a latent to a productive infection is intrinsically involved with the functioning of the human immune system. Activation of T cells has been correlated with the production of a cellular protein, NFkappaB, which binds to specific sites in the HIV promoter and is involved in the initiation of viral RNA transcription. NFkappaB also is important in HIV expression in monocytes/macrophages because monocyte differentiation is associated both with the appearance of NFkappaB-binding activity, which is constitutively produced in mature monocyte/macrophages, and with HIV replication. Tumor necrosis factor-alpha (TNF-alpha) has been shown to be present in significant levels in the sera of patients with AIDS. A recent study showed that the binding of HIV to the CD4 receptor on monocyte/macrophages results in the induction of TNF-alpha. Higher numbers of TNF-alpha receptors are present on the surface of HIV-infected cells when compared to their infected counterparts. Thus, TNF-alpha may alone, or in synergy with other cytokines, function in an autocrine/paracrine loop to enhance replication of HIV and facilitate spread of virus to uninfected cells. If this proves correct in vivo, HIV will have been shown to subvert the usual mechanisms of cytokine-induced immunological activation to its own advantage. (141 Refs)
Keywords: Animal Antigens, CD4/IMMUNOLOGY AIDS Dementia Complex/IMMUNOLOGY Cell Transformation, Viral/IMMUNOLOGY CD4-Positive T-Lymphocytes/*IMMUNOLOGY/MICROBIOLOGY Human HIV/*IMMUNOLOGY/PATHOGENICITY HIV Infections/*IMMUNOLOGY Virus Activation/IMMUNOLOGY MONOGRAPH REVIEW

KWDanimalantigens,cd4/immunologyaidsdementiacomplex/immunologycelltransformation,viral/immunologycd4-positivet-lymphocytes/KWDimmunology/microbiologyhumanhiv/KWDimmunology/pathogenicityhivinfections/KWDimmunologyvirusactivation/immunologymonographreview
920330
M9230753


Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .